Ads
related to: fulc earnings
Search results
Fulcrum Therapeutics, Inc. (FULC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoFulcrum Therapeutics, Inc. (FULC) possesses the right combination of the two key ingredients for a...
Wall Street Analysts Think Fulcrum Therapeutics, Inc. (FULC) Could Surge 71.81%: Read This Before...
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for Fulcrum Therapeutics, Inc. (FULC) points to a 71.8% upside...
Fulcrum Therapeutics, Inc. (FULC) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoFulcrum Therapeutics, Inc. (FULC) delivered earnings and revenue surprises of 19.35% and 45.86%,...
Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights
GuruFocus.com via Yahoo Finance· 7 months agoFulcrum Therapeutics Inc (NASDAQ:FULC) reported a net loss of $24.0 million for Q3 2023, compared to...
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoFulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript February 27, 2024 Fulcrum...
Fulcrum (FULC) Up as FDA Lifts Clinical Hold on SCD Candidate
Zacks via Yahoo Finance· 9 months agoFulcrum's (FULC) shares surge as the FDA lifts the clinical hold it had earlier placed on its...
Are You Looking for a Top Momentum Pick? Why Fulcrum Therapeutics, Inc. (FULC) is a Great Choice
Zacks via Yahoo Finance· 1 year agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Investors in Fulcrum Therapeutics (NASDAQ:FULC) have unfortunately lost 45% over the last year
Simply Wall St. via Yahoo Finance· 9 months agoFulcrum Therapeutics, Inc. (NASDAQ:FULC) shareholders should be happy to see the share price up 18%...
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) institutional owners may be pleased with recent gains after...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Significantly high institutional ownership implies Fulcrum Therapeutics' stock price is...
Further weakness as Fulcrum Therapeutics (NASDAQ:FULC) drops 10% this week, taking one-year losses...
Simply Wall St. via Yahoo Finance· 2 years agoIt is doubtless a positive to see that the Fulcrum Therapeutics, Inc. (NASDAQ:FULC) share price has...
